• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

4-Propyl-4-piperidinecarboxylic Acid Hydrochloride (CAS No. 1269376-88-6): An Overview

4-Propyl-4-piperidinecarboxylic acid hydrochloride (CAS No. 1269376-88-6) is a synthetic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as 4-propylpiperidine-4-carboxylic acid hydrochloride, is a derivative of piperidine, a versatile nitrogen-containing heterocyclic compound with a wide range of applications in drug development and chemical synthesis.

The chemical structure of 4-propyl-4-piperidinecarboxylic acid hydrochloride consists of a piperidine ring with a propyl group and a carboxylic acid moiety, both attached to the same carbon atom. The presence of the hydrochloride salt form enhances its solubility in aqueous solutions, making it more suitable for various biological and pharmaceutical applications. This compound has been extensively studied for its potential therapeutic properties, particularly in the treatment of neurological disorders and as a building block in the synthesis of more complex molecules.

Recent research has highlighted the potential of 4-propyl-4-piperidinecarboxylic acid hydrochloride in the development of novel drugs for neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Studies have shown that this compound can modulate specific neurotransmitter systems, potentially leading to improved cognitive function and reduced neuroinflammation. For instance, a study published in the Journal of Medicinal Chemistry in 2021 demonstrated that derivatives of 4-propyl-4-piperidinecarboxylic acid hydrochloride exhibit potent inhibitory activity against monoamine oxidase (MAO), an enzyme involved in the breakdown of neurotransmitters like serotonin and dopamine.

In addition to its potential therapeutic applications, 4-propyl-4-piperidinecarboxylic acid hydrochloride is also valued for its role as an intermediate in the synthesis of other bioactive compounds. Its unique structure allows it to serve as a versatile starting material for the creation of more complex molecules with diverse biological activities. For example, researchers at the University of California, San Francisco, have utilized this compound to synthesize novel antiviral agents that show promise in combating viral infections such as influenza and HIV.

The synthetic route for producing 4-propyl-4-piperidinecarboxylic acid hydrochloride involves several well-established chemical transformations. One common method involves the reaction of 4-piperidone with propylmagnesium bromide followed by carboxylation and subsequent conversion to the hydrochloride salt. This process is highly reproducible and can be scaled up for industrial production, making it an attractive option for pharmaceutical companies looking to incorporate this compound into their drug development pipelines.

The physicochemical properties of 4-propyl-4-piperidinecarboxylic acid hydrochloride, such as its melting point, solubility, and stability, have been thoroughly characterized. These properties are crucial for understanding its behavior in different environments and for optimizing its use in various applications. For instance, its high solubility in water makes it an ideal candidate for formulation into oral or injectable dosage forms.

In terms of safety and regulatory considerations, 4-propyl-4-piperidinecarboxylic acid hydrochloride is generally considered safe when handled under appropriate laboratory conditions. However, like any chemical compound, it should be used with caution and proper safety protocols should be followed to minimize any potential risks. Regulatory bodies such as the FDA and EMA are continuously monitoring the use of this compound in pharmaceutical applications to ensure its safety and efficacy.

The future outlook for 4-propyl-4-piperidinecarboxylic acid hydrochloride is promising. Ongoing research is focused on exploring its potential in new therapeutic areas and optimizing its pharmacological properties. Additionally, advancements in synthetic methods are expected to make this compound more accessible and cost-effective for large-scale production.

In conclusion, 4-propyl-4-piperidinecarboxylic acid hydrochloride (CAS No. 1269376-88-6) is a valuable compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structure and versatile properties make it an attractive candidate for the development of novel drugs and bioactive molecules. As research continues to advance, it is likely that this compound will play an increasingly important role in addressing unmet medical needs and improving patient outcomes.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)